Non-destructive characterization of optical fiber microstructures: a review [invited]
Chinese Optics Letters · 2026 · 24 (3) · 030008
DOI: 10.3788/col202624.030008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Optics Letters, 2026. Verfasst von Li Pei und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 132 Literaturangaben.
Abstract (Originalsprache)
As optical fiber technology advances toward precision microstructuring, performance limits increasingly arise from microstructural imperfections, such as refractive index distortions, geometric deviations, and residual stresses. Conventional inspection methods lack sufficient resolution and three-dimensional imaging capability. In this paper, we review some major non-destructive characterization techniques, including quantitative phase microscopy, digital holography, X-ray computed tomography, and photoelasticity. Their principles, capabilities, limitations, and demonstrations for practical applications are systematically introduced, offering essential support for designing and manufacturing next-generation high-performance fiber devices.
Zitieren
APA
Pei, L., Wang, C., Wang, J., He, Q., Chang, Y., Zhang, L., Ning, T., Zheng, J., & Hu, Z. (2026). Non-destructive characterization of optical fiber microstructures: a review [invited]. Chinese Optics Letters, 24(3), 030008. https://doi.org/10.3788/col202624.030008
Vancouver
Pei L, Wang C, Wang J, He Q, Chang Y, Zhang L, et al. Non-destructive characterization of optical fiber microstructures: a review [invited]. Chinese Optics Letters. 2026;24(3):030008. doi:10.3788/col202624.030008
BibTeX
@article{Pei2026,
author = {Pei, Li and Wang, Chao and Wang, Jianshuai and He, Qian and Chang, Yanbiao and Zhang, Long and Ning, Tigang and Zheng, Jingjing and Hu, Zhouyi},
title = {Non-destructive characterization of optical fiber microstructures: a review [invited]},
journal = {Chinese Optics Letters},
year = {2026},
volume = {24},
number = {3},
pages = {030008},
doi = {10.3788/col202624.030008}
}
EUVIMED